nobiletin has been researched along with Bone Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Farkas, ME; Harrington, ME; Labriola, C; Lellupitiyage Don, SS; Lin, HH; Robertson, KL; Taylor, SR | 1 |
1 other study(ies) available for nobiletin and Bone Neoplasms
| Article | Year |
|---|---|
Nobiletin affects circadian rhythms and oncogenic characteristics in a cell-dependent manner.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Circadian Rhythm; Flavones; Humans; Osteosarcoma | 2020 |